SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-19-001241
Filing Date
2019-04-05
Accepted
2019-04-05 16:11:12
Documents
8
Effectiveness Date
2019-04-05

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS cvs3508731-defa14a.htm DEFA14A 42947
2 GRAPHIC cvs3508731-defa14ax1x1.jpg GRAPHIC 9500
3 GRAPHIC cvs3508731-defa14ax1x2.jpg GRAPHIC 1623
4 GRAPHIC cvs3508731-defa14ax1x3.jpg GRAPHIC 8020
5 GRAPHIC cvs3508731-defa14ax1x4.jpg GRAPHIC 16117
6 GRAPHIC cvs3508731-defa14ax2x1.jpg GRAPHIC 1670
7 GRAPHIC cvs3508731-defa14ax3x1.jpg GRAPHIC 1715
8 GRAPHIC cvs3508731-defa14ax4x1.jpg GRAPHIC 1614
  Complete submission text file 0001206774-19-001241.txt   100704
Mailing Address ONE CVS DR. WOONSOCKET RI 02895
Business Address ONE CVS DR. WOONSOCKET RI 02895 4017651500
CVS HEALTH Corp (Filer) CIK: 0000064803 (see all company filings)

IRS No.: 050494040 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-01011 | Film No.: 19735256
SIC: 5912 Retail-Drug Stores and Proprietary Stores